BusinessHorizon Pharma plc Presents New Data Analyses Further Demonstrating Clinical Benefit of KRYSTEXXA® (pegloticase) in Patients with Uncontrolled GoutBy Nasdaq OMXJun 14, 2017, 1:05 PM UTC
BusinessEpidemiologic Study Findings Show Over 400 Percent Increase in Gout Patient Hospitalizations Since 1993By Nasdaq OMXJun 14, 2017, 1:00 PM UTC
